All lobbying filings

HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Lobbying for HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $30,000.00 expenses · posted Jan 20, 2026

Official filing document

Bills named in this filing 4

S 998
Medical Supply Chain Resiliency Act
HR 2213
Medical Supply Chain Resiliency Act
S 891
Bipartisan Health Care Act
S 257
Promoting Resilient Supply Chains Act of 2025

Lobbying activity 3

Health Issues

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.

Transportation

S.257, the Promoting Resilient Supply Chains Act of 2025.

Tariff (miscellaneous tariff bills)

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.